234 related articles for article (PubMed ID: 31271873)
21. Immunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein Aggregation.
George S; Brundin P
J Parkinsons Dis; 2015; 5(3):413-24. PubMed ID: 26406122
[TBL] [Abstract][Full Text] [Related]
22. Decreased Toll-Like Receptor 2 and Toll-Like Receptor 7/8-Induced Cytokines in Parkinson's Disease Patients.
da Silva DJ; Borges AF; Souza PO; de Souza PR; Cardoso CR; Dorta ML; de Oliveira MA; Teixeira AL; Ribeiro-Dias F
Neuroimmunomodulation; 2016; 23(1):58-66. PubMed ID: 26886382
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia.
Fellner L; Irschick R; Schanda K; Reindl M; Klimaschewski L; Poewe W; Wenning GK; Stefanova N
Glia; 2013 Mar; 61(3):349-60. PubMed ID: 23108585
[TBL] [Abstract][Full Text] [Related]
24. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
Henderson MX; Trojanowski JQ; Lee VM
Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426
[TBL] [Abstract][Full Text] [Related]
25. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
26. The relation between α-synuclein and microglia in Parkinson's disease: Recent developments.
Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
Neuroscience; 2015 Aug; 302():47-58. PubMed ID: 25684748
[TBL] [Abstract][Full Text] [Related]
27. The Interplay between α-Synuclein and Microglia in α-Synucleinopathies.
Deyell JS; Sriparna M; Ying M; Mao X
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768798
[TBL] [Abstract][Full Text] [Related]
28. Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.
Codolo G; Plotegher N; Pozzobon T; Brucale M; Tessari I; Bubacco L; de Bernard M
PLoS One; 2013; 8(1):e55375. PubMed ID: 23383169
[TBL] [Abstract][Full Text] [Related]
29. Early minor stimulation of microglial TLR2 and TLR4 receptors attenuates Alzheimer's disease-related cognitive deficit in rats: behavioral, molecular, and electrophysiological evidence.
Pourbadie HG; Sayyah M; Khoshkholgh-Sima B; Choopani S; Nategh M; Motamedi F; Shokrgozar MA
Neurobiol Aging; 2018 Oct; 70():203-216. PubMed ID: 30031930
[TBL] [Abstract][Full Text] [Related]
30. Alpha-synuclein at the nexus of genes and environment: the impact of environmental enrichment and stress on brain health and disease.
Wassouf Z; Schulze-Hentrich JM
J Neurochem; 2019 Sep; 150(5):591-604. PubMed ID: 31165472
[TBL] [Abstract][Full Text] [Related]
31. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs.
Olson JK; Miller SD
J Immunol; 2004 Sep; 173(6):3916-24. PubMed ID: 15356140
[TBL] [Abstract][Full Text] [Related]
32. Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts.
Strohäker T; Jung BC; Liou SH; Fernandez CO; Riedel D; Becker S; Halliday GM; Bennati M; Kim WS; Lee SJ; Zweckstetter M
Nat Commun; 2019 Dec; 10(1):5535. PubMed ID: 31797870
[TBL] [Abstract][Full Text] [Related]
33. TLR4 and TLR2 activation is differentially associated with age during Parkinson's disease.
Rocha Sobrinho HMD; Silva DJD; Gomides LF; Dorta ML; Oliveira MAP; Ribeiro-Dias F
Immunol Invest; 2018 Jan; 47(1):71-88. PubMed ID: 29077524
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential.
Dabi YT; Ajagbe AO; Degechisa ST
Immun Inflamm Dis; 2023 Apr; 11(4):e839. PubMed ID: 37102648
[TBL] [Abstract][Full Text] [Related]
35. Reduced cerebral blood flow in an
Biju KC; Shen Q; Hernandez ET; Mader MJ; Clark RA
J Cereb Blood Flow Metab; 2020 Dec; 40(12):2441-2453. PubMed ID: 31856640
[TBL] [Abstract][Full Text] [Related]
36. The expression of Toll-like receptors in murine Müller cells, the glial cells in retina.
Lin X; Fang D; Zhou H; Su SB
Neurol Sci; 2013 Aug; 34(8):1339-46. PubMed ID: 23207548
[TBL] [Abstract][Full Text] [Related]
37. Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders.
Daniele SG; Béraud D; Davenport C; Cheng K; Yin H; Maguire-Zeiss KA
Sci Signal; 2015 May; 8(376):ra45. PubMed ID: 25969543
[TBL] [Abstract][Full Text] [Related]
38. Neurons and Glia Interplay in α-Synucleinopathies.
Mavroeidi P; Xilouri M
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066733
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity in gut microbiota drive polyphenol metabolism that influences α-synuclein misfolding and toxicity.
Ho L; Zhao D; Ono K; Ruan K; Mogno I; Tsuji M; Carry E; Brathwaite J; Sims S; Frolinger T; Westfall S; Mazzola P; Wu Q; Hao K; Lloyd TE; Simon JE; Faith J; Pasinetti GM
J Nutr Biochem; 2019 Feb; 64():170-181. PubMed ID: 30530257
[TBL] [Abstract][Full Text] [Related]
40. Role of toll-like receptor signalling in Abeta uptake and clearance.
Tahara K; Kim HD; Jin JJ; Maxwell JA; Li L; Fukuchi K
Brain; 2006 Nov; 129(Pt 11):3006-19. PubMed ID: 16984903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
